Cannabidiol: a promising drug for neurodegenerative disorders?

Key Findings:  Cannabidiol (CBD) may represent a very promising agent with the highest prospect for therapeutic use in the treatment of neurodegenerative illness.

Type of Study:  Meta-analysis

Study Result:  Positive

Cannabinoids Studied:  Cannabidiol (CBD)

Phytocannabinoid Source:  Not Applicable

Chemotype:  Chemotype III

Form of Administration:  Not Applicable

Study Location(s):  Italy

Year of Pub:  2009

Link to study